Table 1. Serum NDKA levels in the screening cohort according to demographic and clinical characteristics.
Characteristics | N | Median (pg/mL) | IQR (pg/mL) | P |
---|---|---|---|---|
Age (years) | ||||
≤49 | 177 | 55.88 | 45.91–67.76 | 0.259a |
50–59 | 172 | 58.80 | 46.64–70.32 | |
≥60 | 162 | 60.25 | 47.86–70.95 | |
Gender | ||||
Male | 210 | 58.80 | 47.15–71.14 | 0.354b |
Female | 301 | 58.31 | 46.57–68.36 | |
Familial risk | ||||
1 FDR ≥ 60 years | 340 | 58.80 | 46.88–69.72 | 0.985a |
1 FDR < 60 years | 117 | 57.23 | 46.38–69.44 | |
≥2 FDR | 54 | 56.15 | 45.02–74.58 |
IQR: interquartile range; aKruskal-Wallis test, bMann-Whitney U test. FDR: first-degree relative.